Difference between revisions of "Wright MH, et al. Breast Cancer Res. (2008) cited as Ref 664 in DOI: 10.1038/s41392-020-0110-5 (Q9927)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: PubMed ID (P140): 18241344, #quickstatements; #temporary_batch_1590001671040)
(‎Created claim: Page(s) (P105): R10-, #quickstatements; #temporary_batch_1590074839150)
 
(4 intermediate revisions by the same user not shown)
Property / Publication Date
 +
2008
Timestamp+2008-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2008 / rank
 +
Normal rank
Property / Published In Name String
 +
Breast Cancer Res.
Property / Published In Name String: Breast Cancer Res. / rank
 +
Normal rank
Property / Volume
 +
10
Property / Volume: 10 / rank
 +
Normal rank
Property / title
 +
Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics (English)
Property / title: Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics (English) / rank
 +
Normal rank
Property / Page(s)
 +
R10-
Property / Page(s): R10- / rank
 +
Normal rank

Latest revision as of 15:48, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Wright MH, et al. Breast Cancer Res. (2008) cited as Ref 664 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Wright MH
    0 references
    0 references
    2008
    0 references
    Breast Cancer Res.
    0 references
    10
    0 references
    Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics (English)
    0 references
    R10-
    0 references